T-regulatory 1 cells: a novel subset of CD4 T cells with immunoregulatory properties.
暂无分享,去创建一个
[1] M. Roncarolo,et al. A transgenic model to analyze the immunoregulatory role of IL-10 secreted by antigen-presenting cells. , 1999, Journal of immunology.
[2] N. Van Rooijen,et al. Immunoregulatory role of IL-10 during superantigen-induced hyporesponsiveness in vivo. , 1997, Journal of immunology.
[3] R. Locksley,et al. Altered Immune Responses in Interleukin 10 Transgenic Mice , 1997, The Journal of experimental medicine.
[4] B. Benacerraf,et al. Suppressor cells and immunoregulation. , 1984, Annual review of immunology.
[5] F. Ruscetti,et al. Induction of CD4+ T cell alloantigen-specific hyporesponsiveness by IL-10 and TGF-beta. , 1999, Journal of immunology.
[6] L. Li,et al. Emergence of regulatory CD4+ T cell response to repetitive stimulation with antigen-presenting cells in vitro: implications in designing antigen-presenting cell-based tumor vaccines. , 1999, Journal of immunology.
[7] J. Rolland,et al. Immunotherapy of allergy: anergy, deletion, and immune deviation. , 1998, Current opinion in immunology.
[8] T. Mosmann,et al. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. , 1990, Science.
[9] P. Subramaniam,et al. Mechanism of Interleukin-10 Inhibition of T-Helper Cell Activation by Superantigen at the Level of the Cell Cycle , 1999 .
[10] M. Sporn,et al. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[11] A. O’Garra,et al. Cytokines induce the development of functionally heterogeneous T helper cell subsets. , 1998, Immunity.
[12] J. D. de Vries,et al. Chimerism and tolerance to host and donor in severe combined immunodeficiencies transplanted with fetal liver stem cells. , 1993, The Journal of clinical investigation.
[13] H. Boehmer,et al. Tolerance in T-cell-receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes , 1988, Nature.
[14] F. Powrie,et al. Interleukin 10 is a growth factor for a population of regulatory T cells , 1998, Gut.
[15] G. Trinchieri,et al. Molecular mechanisms of the induction of IL-12 and its inhibition by IL-10. , 1998, Journal of immunology.
[16] J. Abrams,et al. Host-reactive CD4+ and CD8+ T cell clones isolated from a human chimera produce IL-5, IL-2, IFN-gamma and granulocyte/macrophage-colony-stimulating factor but not IL-4. , 1990, Journal of immunology.
[17] J. D. de Vries,et al. A SCID patient reconstituted with HLA-incompatible fetal stem cells as a model for studying transplantation tolerance. , 1991, Blood cells.
[18] C. Akdis,et al. Role of interleukin 10 in specific immunotherapy. , 1998, The Journal of clinical investigation.
[19] R. de Waal Malefyt,et al. High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells , 1994, The Journal of experimental medicine.
[20] Hervé Groux,et al. A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis , 1997, Nature.
[21] R. Lechler,et al. Anergic T cells as suppressor cells in vitro. , 1994, Science.
[22] H. Weiner,et al. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. , 1994, Science.
[23] CD4+ T cell down-regulation in human intestinal mucosa: evidence for intestinal tolerance to luminal bacterial antigens. , 1997, Journal of immunology.
[24] W. van Eden,et al. Dose-dependent induction of distinct anergic phenotypes: multiple levels of T cell anergy. , 1999, Journal of immunology.
[25] M. Goldman,et al. Interleukin‐10 differentially regulates B7‐1 (CD80) and B7‐2 (CD86) expression on human peripheral blood dendritic cells , 1995, European journal of immunology.
[26] D. Mason,et al. Control of immune pathology by regulatory T cells. , 1998, Current opinion in immunology.
[27] R. Coffman,et al. Transgenic Interleukin 10 Prevents Induction of Experimental Autoimmune Encephalomyelitis , 1999, The Journal of experimental medicine.
[28] F. Autschbach,et al. T cells of the human intestinal lamina propria are high producers of interleukin-10 , 1997, Gut.
[29] W. van Eden,et al. Anergic T cells actively suppress T cell responses via the antigen‐presenting cell , 1998, European journal of immunology.
[30] R. Schwartz,et al. Antigen presentation by chemically modified splenocytes induces antigen- specific T cell unresponsiveness in vitro and in vivo , 1987, The Journal of experimental medicine.
[31] H. Jun,et al. A new type of CD4+ suppressor T cell completely prevents spontaneous autoimmune diabetes and recurrent diabetes in syngeneic islet-transplanted NOD mice. , 1996, Journal of autoimmunity.
[32] J. Buer,et al. Interleukin 10 Secretion and Impaired Effector Function of Major Histocompatibility Complex Class II–restricted T Cells Anergized In Vivo , 1998, The Journal of experimental medicine.
[33] R. Schwartz,et al. Models of T Cell Anergy: Is There a Common Molecular Mechanism? , 1996 .
[34] C G Figdor,et al. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes , 1991, The Journal of experimental medicine.
[35] C. Figdor,et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression , 1991, The Journal of experimental medicine.
[36] J. D. de Vries,et al. Autoreactive T cell clones specific for class I and class II HLA antigens isolated from a human chimera , 1988, The Journal of experimental medicine.
[37] M. Roncarolo,et al. High spontaneous IL-10 production in unrelated bone marrow transplant recipients is associated with fewer transplant-related complications and early deaths , 1999, Bone Marrow Transplantation.
[38] R. Coffman,et al. A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells , 1996, The Journal of experimental medicine.
[39] I. Bernard,et al. Transforming Growth Factor β (TGF-β)-dependent Inhibition of T Helper Cell 2 (Th2)-induced Autoimmunity by Self–Major Histocompatibility Complex (MHC) Class II–specific, Regulatory CD4+ T Cell Lines , 1997, The Journal of experimental medicine.
[40] K. Rajewsky,et al. Interleukin-10-deficient mice develop chronic enterocolitis , 1993, Cell.
[41] J. D. de Vries,et al. Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells , 1996, The Journal of experimental medicine.
[42] B. Rocha,et al. Peripheral selection of the T cell repertoire. , 1991, Science.
[43] R. Schwartz,et al. Anergy and Cytokine-Mediated Suppression as Distinct Superantigen-Induced Tolerance Mechanisms in Vivo , 1999, The Journal of experimental medicine.
[44] S. Nakagawa,et al. Interferon‐γ and interleukin‐10 inhibit antigen presentation by Langerhans cells for T helper type 1 cells by suppressing their CD80 (B7‐1) expression , 1996, European journal of immunology.